Table 1.
Infection | Secretors more susceptible | Nonsecretors more susceptible | Refs |
---|---|---|---|
Norovirus (GII.4) | ✔ | 21, 74 | |
Rotavirus (VP8) | ✔ | 36, 37, 38 | |
Influenza A virus | ✔ | [19] | |
Rhinovirus | ✔ | [19] | |
Echovirus | ✔ | [19] | |
RSV | ✔ | [19] | |
HIV | ✔ | 16, 17, 18 | |
Helicobacter pylori | ✔ | 24, 75, 76 | |
Candida albicans | ✔ | 77, 78 | |
Streptococcus pneumoniae | ✔ | [22] | |
Neisseria meningitidis | ✔ | [22] | |
Haemophilus influenzae | ✔ | [23] | |
Salmonella enterica serovar Typhimuriumb | ✔ | [11] | |
Citrobacter rodentiumb | ✔ | [9] | |
Campylobacter jejuni | ✔ | 41, 42 | |
Urinary tract infection | ✔ | 79, 80 | |
Bacteraemia (after haematopoietic stem cell transplantation) | ✔ | [81] | |
Disease | Secretors more susceptible | Nonsecretors more susceptible | Refs |
Non-CF bronchiectasis severityc | ✔ | [67] | |
Asthma severity | ✔ | [82] | |
Graft-versus-host disease | ✔ | [81] | |
Intestinal-type gastric cancer | ✔ | [83] | |
Primary sclerosing cholangitis | ✔ | [84] | |
Crohn’s disease | ✔ | 53, 85 | |
Celiac disease | ✔ | [86] | |
Asthma | ✔ | 26, 27 | |
Type 1 diabetes | ✔ | [28] | |
High plasma vitamin B12 | ✔ | 87, 88, 89 | |
Chronic pancreatitis | ✔ | [25] | |
Psoriasis | ✔ | [29] | |
Acute uncomplicated pyelonephritis | ✔ | [90] | |
Behçet’s disease | ✔ | [91] |
Secretor phenotype is associated with increased susceptibility to viral infections and respiratory disease severity, but with decreased susceptibility to bacterial infections and a diverse range of chronic inflammatory diseases.
Demonstrated in Fut2–/– mice with no human epidemiological evidence.
Abbreviation: CF, cystic fibrosis.